Your browser doesn't support javascript.
loading
Clinical criteria for Mucosal Leishmaniasis diagnosis in rural South America: A systematic literature review.
Bezemer, Jacob M; Meesters, Kevin; Naveda, Cristhian L; Machado, Paulo R L; Calvopiña, Manuel; Leeflang, Mariska M G; Schallig, Henk D F H; de Vries, Henry J C.
Afiliação
  • Bezemer JM; Fundación Misión Cristiana de Salud, Shell, Pastaza, Ecuador.
  • Meesters K; Department of Medical Microbiology and Infection Prevention, Laboratory for Experimental Parasitology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
  • Naveda CL; Amsterdam Institute for infection and Immunity (AII), Infectious Diseases Program, Amsterdam, the Netherlands.
  • Machado PRL; Department of Pediatrics, Division of Infectious Diseases, University of British Columbia, Vancouver, Canada.
  • Calvopiña M; Fundación Misión Cristiana de Salud, Shell, Pastaza, Ecuador.
  • Leeflang MMG; Serviço de Imunologia, Hospital Universitário Prof. Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brazil.
  • Schallig HDFH; OneHealth Research Group, Carrera de Medicina, Facultad de Ciencias de la Salud, Universidad de las Americas, Quito, Ecuador.
  • de Vries HJC; Department of Epidemiology and Data Science, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
PLoS Negl Trop Dis ; 16(8): e0010621, 2022 08.
Article em En | MEDLINE | ID: mdl-35947553
BACKGROUND: Mucosal Leishmaniasis (ML), a neglected tropical disease caused by Leishmania parasites, impairs the quality of life of under-resourced populations in South America. If not treated promptly, this disease progresses to facial deformities and death. The low sensitivity of microscopy results and the unavailability of other accurate tests hamper the diagnosis. As clinical criteria are readily available in any setting, these may be combined in a syndromic algorithm, which in turn can be used as a diagnostic tool. We explore potential clinical criteria for a syndromic diagnostic algorithm for ML in rural healthcare settings in South America. METHODOLOGY/PRINCIPAL FINDINGS: The protocol for this systematic review was pre-registered in PROSPERO with the number: CRD42017074148. In patients with ML, described in case series identified through a systematic retrieval process, we explored the cumulative ML detection rates of clinical criteria. Participants: all patients with active mucosal disease from an endemic area in South America. Any original, non-treatment study was eligible, and case reports were excluded. PUBMED, EMBASE, Web of Science, SCIELO, and LILACS databases were searched without restrictions. The risk of bias was assessed with the JBI checklist for case series. We included 10 full texts describing 192 ML patients. Male gender had the highest detection rate (88%), followed by ulcer of the nasal mucosa (77%), age >15 (69%), and symptom duration >4 months (63%). SIGNIFICANCE: Within this selection of patients, we found that the male gender, ulcer of the nasal mucosa, age >15, and symptom duration >4 months lead to the highest detection rates. However, higher detection comes -naturally- with a higher rate of false positives as well. As we only included ML patients, this could not be verified. Therefore, the criteria that we found to be most promising should be validated in a well-designed prospective study.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leishmaniose Mucocutânea / Leishmania Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Infant / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leishmaniose Mucocutânea / Leishmania Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Infant / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article